Baumann Oliver Rolf
SEC CIK 2129436 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRXA | Veraxa Biotech AG - Post de-SPAC | Dir | 5.77M | $75.0K | — | 1 | 2026-08-27 | 2026-08-27 |
Most active insiders at VRXA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Baumann Oliver Rolf | Dir | $75.0K | — |
| 2 | Antz Christoph Rudiger | CEO, Dir | $7,650 | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-31 16:10 | 2026-08-27 | VRXA | Veraxa Biotech AG - Post de-SPAC | Baumann Oliver Rolf | Dir | P - Purchase | $1.50 | +50.0K | 5.77M | +0.9% | +$75.0K |
Purchase Sale Sale after option exercise All abbreviations